Product Code: ETC8539348 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Geriatric Medicines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Geriatric Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Geriatric Medicines Market - Industry Life Cycle |
3.4 Netherlands Geriatric Medicines Market - Porter's Five Forces |
3.5 Netherlands Geriatric Medicines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Netherlands Geriatric Medicines Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Netherlands Geriatric Medicines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Netherlands Geriatric Medicines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Netherlands Geriatric Medicines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Geriatric Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the Netherlands |
4.2.2 Rising prevalence of chronic diseases among the elderly |
4.2.3 Technological advancements in geriatric medicine |
4.2.4 Growing awareness about the importance of geriatric healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies in the pharmaceutical industry |
4.3.2 High costs associated with research and development of geriatric medicines |
4.3.3 Limited access to specialized geriatric healthcare services |
4.3.4 Potential side effects and risks associated with geriatric medications |
5 Netherlands Geriatric Medicines Market Trends |
6 Netherlands Geriatric Medicines Market, By Types |
6.1 Netherlands Geriatric Medicines Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Geriatric Medicines Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Netherlands Geriatric Medicines Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.4 Netherlands Geriatric Medicines Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.1.5 Netherlands Geriatric Medicines Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.6 Netherlands Geriatric Medicines Market Revenues & Volume, By Neurological, 2021- 2031F |
6.1.7 Netherlands Geriatric Medicines Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 Netherlands Geriatric Medicines Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.1.9 Netherlands Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Netherlands Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Geriatric Medicines Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Geriatric Medicines Market Revenues & Volume, By Analgesic, 2021- 2031F |
6.2.3 Netherlands Geriatric Medicines Market Revenues & Volume, By Antihypertensive, 2021- 2031F |
6.2.4 Netherlands Geriatric Medicines Market Revenues & Volume, By Statins, 2021- 2031F |
6.2.5 Netherlands Geriatric Medicines Market Revenues & Volume, By Antidiabetic, 2021- 2031F |
6.2.6 Netherlands Geriatric Medicines Market Revenues & Volume, By Proton Pump Inhibitor, 2021- 2031F |
6.2.7 Netherlands Geriatric Medicines Market Revenues & Volume, By Anticoagulant, 2021- 2031F |
6.3 Netherlands Geriatric Medicines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Geriatric Medicines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Netherlands Geriatric Medicines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Netherlands Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Geriatric Medicines Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Geriatric Medicines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Netherlands Geriatric Medicines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Netherlands Geriatric Medicines Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Netherlands Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Geriatric Medicines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Geriatric Medicines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Netherlands Geriatric Medicines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Netherlands Geriatric Medicines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Netherlands Geriatric Medicines Market Import-Export Trade Statistics |
7.1 Netherlands Geriatric Medicines Market Export to Major Countries |
7.2 Netherlands Geriatric Medicines Market Imports from Major Countries |
8 Netherlands Geriatric Medicines Market Key Performance Indicators |
8.1 Average length of hospital stays for geriatric patients |
8.2 Number of geriatric clinics and specialized healthcare facilities |
8.3 Percentage of elderly population receiving regular geriatric check-ups |
8.4 Adoption rate of innovative geriatric medicines and treatments |
8.5 Patient satisfaction scores in geriatric healthcare services |
9 Netherlands Geriatric Medicines Market - Opportunity Assessment |
9.1 Netherlands Geriatric Medicines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Netherlands Geriatric Medicines Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Netherlands Geriatric Medicines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Netherlands Geriatric Medicines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Netherlands Geriatric Medicines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Geriatric Medicines Market - Competitive Landscape |
10.1 Netherlands Geriatric Medicines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Geriatric Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |